Companies /Healthcare

High Tide Inc

NASDAQ: HITI Pharmaceutical Retailers
$2.76
▲ $0.13 (+4.94%) today
Markets closed · 1:53am ET

Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
100%
EPS beat rate
+241.47%
Avg. EPS surprise
Consecutive EPS beats
HITI vs Market · 30-day return after each reportHITIS&P 500
−16%−8%0%+8%−7.3%+0.1%Q3 25+10.7%−2.0%Q4 25+0.8%+7.2%Q1 26−14.3%−1.1%Q2 26
−16%−8%0%+8%Q3 25Q4 25Q1 26Q2 26
HITI EPS Trend · estimate vs actualEstimateActual
$0.00$0.03$0.06$0.09$-0.01$0.01Q3 25$0.01$0.01Q4 25$0.00$0.01Q1 26$-0.02$0.01Q2 26$0.02$0.09Q3 26
$0.00$0.03$0.06$0.09Q3 25Q4 25Q1 26Q2 26Q3 26
HITI Revenue Trend · estimate vs actualEstimateActual
$0$60.0M$120.0M$180.0M$147.9M$109.5MQ3 25$159.0M$120.0MQ4 25$173.8M$130.4MQ1 26$171.7M$128.2MQ2 26$194.6M$143.1MQ3 26
$0$60.0M$120.0M$180.0MQ3 25Q4 25Q1 26Q2 26Q3 26

Quarter by Quarter

Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Includes a CAD $11,787 thousand gain on fair value change in derivative liability and a CAD $1,285 thousand loss on fair value change in long-term contract asset; adjusted net income excluding these items was CAD $2,246 thousand $0.09 est. $0.02 +311.43% $143.1M est. $194.6M −26.46%
Q2 2026 $0.01 est. $-0.02 — $128.2M est. $171.7M −25.34%
Q1 2026 $0.01 est. $0.00 +265.00% $130.4M est. $173.8M −24.95%
Q4 2025 $0.01 est. $0.01 +151.72% $120.0M est. $159.0M −24.56%
Q3 2025 $0.01 est. $-0.01 +237.74% $109.5M est. $147.9M −25.96%

Figures from SEC filings and company reports. Not investment advice.